Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiographic and Clinical Outcomes of Stress Endplate Augmentation in Patients With Low Bone Mass Undergoing Oblique Lumbar Interbody Fusion for Degenerative Lumbar Disease: A Prospective Observational Cohort Study

NCT07891663 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07891663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Radiographic and Clinical Outcomes of Stress Endplate Augmentation in Patients With Low Bone Mass Undergoing Oblique Lumbar Interbody Fusion for Degenerative Lumbar Disease: A Prospective Observational Cohort Study
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
December 1, 2029
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative lumbar disease

Arms

As registered; 2 arms.

  • OLIF With Stress Endplate Augmentation

    Patients with low bone mass and degenerative lumbar disease undergoing oblique lumbar interbody fusion (OLIF) with stress endplate augmentation of the vertebral bone adjacent to the endplates supporting the interbody cage.

  • OLIF Without Stress Endplate Augmentation

    Patients with low bone mass and degenerative lumbar disease undergoing OLIF without stress endplate augmentation.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Cage Subsidence at 18 Months After Surgery Postoperative predischarge imaging as the reference and 18 months after surgery; subsidence-related revision surgery assessed through 18 months.

    Number of participants with interbody cage subsidence, defined as a decrease of more than 2 mm in intervertebral disc height at any operated level compared with the postoperative predischarge imaging reference. A participant with subsidence at one or more operated levels is counted once. Participants undergoing revision surgery for cage subsidence before the 18-month assessment are also counted as having the outcome.

Lead sponsor's other trials

Xuanwu Hospital, Beijing, most recent start first.